Restless legs syndrome (RLS) is a common sensorimotor disorder characterized by an urge
to move that appears during rest or is exacerbated by rest, that occurs in the evening or night …

Restless legs syndrome (RLS) is a common disorder. The population prevalence is 1.5% to
2.7% in a subgroup of patients having more severe RLS with symptoms occurring 2 or more …

Background In 2003, following a workshop at the National Institutes of Health, the
International Restless Legs Syndrome Study Group (IRLSSG) developed updated …

Compared with younger people, elderly people show age‐related sleep changes, including
an advanced sleep phase and decreased slow‐wave sleep, which result in fragmented …

Restless legs syndrome (RLS) has gained considerable attention in the recent years: nearly
50 community-based studies have been published in the last decade around the world. The …

Sleep disorders are frequent (18%–23%) and constitute a major risk factor for psychiatric,
cardiovascular, metabolic or hormonal co-morbidity and mortality. Low social status or …

Objective There is a surging public interest in The Netherlands concerning sleep, sleep
disorders and associated health. For a proper perspective, it is necessary to have reliable …

Restless Legs Syndrome (RLS) a common, under‐recognized disorder disrupts sleep and
diminishes quality of life. Despite a clear relation between low peripheral iron and increased …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
and may frequently be complicated by sleep disorders. Insomnia and obstructive sleep …

Background Dopaminergic medications relieve symptoms of the restless legs syndrome
(RLS) but have the potential to cause iatrogenic worsening (augmentation) of RLS with long …